有机化学 ›› 2012, Vol. 32 ›› Issue (02): 376-381 .DOI: 10.6023/cjoc1104222 上一篇    下一篇

研究论文

新型二氧代氮杂茂并[3',4'-d]N-甲基异噁唑四氯化铁酸盐衍生物的合成及其生物活性

图尔麦麦提·艾力, 穆赫塔尔·伊米尔艾山, 阿依努尔·胡达依别尔根   

  1. 新疆大学化学与化工学院 乌鲁木齐 830046
  • 收稿日期:2011-04-22 修回日期:2011-09-14 发布日期:2012-03-09
  • 通讯作者: 穆赫塔尔·伊米尔艾山 E-mail:imerhasan@xju.edu.cn
  • 基金资助:

    国家自然科学基金(No. 21062019)资助项目.

Synthesis and Bioactivity of Novel Dioxy-pyrrolino[3',4'-d]-N-methylisoxazolinium-tetrachloroferrate Derivatives

Turmuhammad Ali, Mukhtar Imerhasan, Aynur Hudabergen   

  1. College of Chemistry and Chemical Engineering, Xinjiang University, Urumqi 830046
  • Received:2011-04-22 Revised:2011-09-14 Published:2012-03-09
  • Supported by:

    Project supported by the National Natural Science Foundation of China (No. 21062019).

硫酸二甲酯作为N-甲基化试剂, 与相应的异噁唑啉反应, 并在盐酸中三氯化铁作为阴离子交换试剂, 合成了15个未见文献报道的2-甲基-3-(1',2'-二-O-环亚己基二氧乙基)-5-芳基-3a,6a-二氢-4,6-二氧代氮杂茂并[3',4'-d]异噁唑四氯化铁酸盐衍生物4a4o. 化合物4a4o 结构结构经1H NMR, IR 和元素分析确证, 并进行了初步药物活性筛选, 大部分化合物显示了不同程度的抗癌和抗炎症性及免疫性疾病活性. 体外抗癌活性试验表明, 当样品浓度为20 μg/mL 时,除了4h 无活性外, 其余化合物对细胞分裂周期磷酸酯酶Cdc25B 的抑制率为≥97.55%. 此外, 体外白细胞共同抗原活性试验表明, 当样品浓度为20 μg/mL 时, 所有化合物4a4o 对白细胞共同抗原CD45 蛋白酪氨酸磷酸酶A 具有良好的抑制活性, 其抑制率为68.41%~93.38%. 在此基础上, 初步讨论了该类化合物的构效关系.

关键词: N-甲基异噁唑四氯化铁酸盐, 合成, 生物活性

Fifteen novel 2-methyl-3-(1',2'-O-cyclohexylidendioxyethyl)-5-aryl-3a,6a-dihydro-4,6-dioxopyrrolino[3',4'-d]- isoxazolinium-tetrachloroferrate derivatives 4a4o were synthesized by N-methylation of the corresponding isoxazoline using dimethyl sulfate as a methylating reagent and ferric(III)-chloride as anion exchange reagent in hydrochloric acid. The structures of the target compounds 4a4o were characterized by 1H NMR, IR spectra and elemental analysis. The preliminary in vitro bioassay on the compounds showed that most compounds possess anti-cancer activity and the Leukocyte common antigen activity at some extent. At the test concentration of 20 μg/mL, all compounds showed inhibition activity of ≥97.55% against Cdc25B (cell division cycle 25B) phosphatase except for compound 4h, and inhibition activity of 68.41%~93.38% against leukocyte common antigen (LCK) CD45 protein tyrosine phosphatase A, respectively. Preliminary discussion was carried out on the structure-activity relationship of the target compounds.

Key words: N-methylisoxazolinium-tetrachloroferrate, synthesis, bioactivity